Levodopa therapy in a Lesch-Nyhan disease patient: Pathological, biochemical, neuroimaging, and therapeutic remarks

Movement Disorders

Volumn 23, Issue 9, 2008, Pages 1297-1300

  Serrano, Mercedes ^a,b   Pérez Dueñas, Belen ^a,b   Ormazábal, Aida ^a,b   Artuch, Rafael ^a,b   Campistol, Jaume ^a,b   Torres, Rosa J ^c   García Cazorla, Angels ^a,b,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Cerebrospinal fluid; Dopamine; Lesch Nyhan disease; Lumbar puncture; Monoamines; Neurotransmitter

Indexed keywords

ADENINE PHOSPHORIBOSYLTRANSFERASE; CARBIDOPA PLUS LEVODOPA; FOLINIC ACID; GLYCINE; HOMOVANILLIC ACID; HYPOXANTHINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; TYROSINE 3 MONOOXYGENASE; XANTHINE;

ARTICLE; BABINSKI REFLEX; BRAIN CORTEX ATROPHY; BRAIN RADIOGRAPHY; CASE REPORT; CODON; DRUG EFFICACY; DYSTONIA; ENZYME ACTIVITY; ENZYMURIA; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; HEAD CIRCUMFERENCE; HEAD POSITION; HUMAN; INFANT; LESCH NYHAN SYNDROME; LUMBAR PUNCTURE; MALE; MOVEMENT PERCEPTION; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT RESPONSE; TREMOR; URIC ACID BLOOD LEVEL;

CHILD, PRESCHOOL; DOPAMINE AGENTS; HUMANS; LESCH-NYHAN SYNDROME; LEVODOPA; MALE; TREATMENT OUTCOME;

EID: 52649083272     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21786     Document Type: Article

References (15)

1. Jinnah HA, Friedmann T. Lesch-Nyhan disease and its variants. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, 8th ed. New York: McGraw-Hill; 2001. p 2537-2570.
2. Jinnah HA, Visser JE, Harris JC, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 2006;129:1201-1217.
3. Ormazábal A, García-Cazorla A, Fernández Y, Fernández-Álvarez E, Campistol J, Artuch R. HPLC with electrochemical and fluorescence detection procedures for the diagnosis of inborn errors of biogenic amines and pterines. J Neurosci Methods 2005; 142:153-158.
4. Lloyd KG, Hornykiewicz O, Davidson L, et al. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med 1981; 305:1106-1111.
5. Saito Y, Ito M, Hanaoka S, Ohama E, Akaboshi S, Takashima S. Dopamine receptor upregulation in Lesch-Nyhan syndrome: a postmortem study. Neuropediatrics 1999;30:66-71.
6. Ernst M, Zametkin AJ, Matochik JA, et al. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Eng J Med 1996;334: 1568-1572.
7. Wong DF, Harris JC, Naidu S, et al. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci USA 1996;93:5539-5543.
8. Herlenius E, Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum Dev 2001;65:21-37.
9. Schmidt U, Beyer C, Oestreicher AB, Reisert I, Schilling K, Pilgrim C. Activation of dopaminergic D1 receptors promotes morphogenesis of developing striatal neurons. Neuroscience 1996; 74:453-460.
10. Castells S, Chakrabarti C, Winsberg BG, Hurwic M, Perel JM, Nyhan WL. Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome. J Autism Dev Disord 1979;9:95-103.
11. Ciaranello RD, Anders TF, Barchas JD, Berger PA, Cann HM. The use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome. Child Psychiatry Hum Dev 1976;7:127-133.
12. Jankovic J, Caskey TC, Stout JT, Butler U. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Ann Neurol 1988;23:466-469.
13. Silverstein FS, Johnston MV, Hutchinson RJ, Edwards NL. Lesch-Nyhan syndrome: CSF neurotransmitter abnormalities. Neurology 1985;35:907-911.
14. Watts RWE,, Spellacy E, Gibbs DA, Allsop J, McKeran RO, Slavin GE. Clinical, post-mortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the neurological manifestations. QJMed 1982;51:43-78.
15. Mizuno T, Yugari Y. Self-mutilation in Lesch-Nyhan syndrome. Lancet 1974;1:761.